These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 11544566

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. TSH-receptor autoantibodies - differentiation of hyperthyroidism between Graves' disease and toxic multinodular goitre.
    Wallaschofski H, Kuwert T, Lohmann T.
    Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):171-4. PubMed ID: 15127319
    [Abstract] [Full Text] [Related]

  • 3. Detecting TSH-receptor antibodies with the recombinant TBII assay: technical and clinical evaluation.
    Schott M, Feldkamp J, Bathan C, Fritzen R, Scherbaum WA, Seissler J.
    Horm Metab Res; 2000 Oct; 32(10):429-35. PubMed ID: 11069209
    [Abstract] [Full Text] [Related]

  • 4. [Clinical implications of a new TSH receptor antibody assay (DYNOtest TRAKhuman) in autoimmune thyroid diseases].
    Meller J, Schreivogel I, Bergmann A, Morgenthaler N, Hüfner M, Becker W.
    Nuklearmedizin; 2000 Oct; 39(1):14-8. PubMed ID: 10726252
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of the 2nd generation radio-receptional assay for anti-TSH receptor antibodies (TRAb) in autoimmune thyroid diseases. Comparison with 1st generation and anti-thyroperoxidase antibodies (AbTPO).
    Giovanella L, Ceriani L, Garancini S.
    Q J Nucl Med; 2001 Mar; 45(1):115-9. PubMed ID: 11456370
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. TSH receptor antibody (TRAb) assays based on the human monoclonal autoantibody M22 are more sensitive than bovine TSH based assays.
    Zöphel K, Roggenbuck D, von Landenberg P, Wunderlich G, Grüning T, Kotzerke J, Lackner KJ, Rees Smith B.
    Horm Metab Res; 2010 Jan; 42(1):65-9. PubMed ID: 19830651
    [Abstract] [Full Text] [Related]

  • 8. Clinical value of a new TSH binding inihibitory activity assay using human TSH receptors in the follow-up of antithyroid drug treated Graves' disease. Comparison with thyroid stimulating antibody bioassay.
    Maugendre D, Massart C.
    Clin Endocrinol (Oxf); 2001 Jan; 54(1):89-96. PubMed ID: 11167931
    [Abstract] [Full Text] [Related]

  • 9. Stimulating and blocking thyroid-stimulating hormone (TSH) receptor autoantibodies from patients with Graves' disease and autoimmune hypothyroidism have very similar concentration, TSH receptor affinity, and binding sites.
    Morgenthaler NG, Ho SC, Minich WB.
    J Clin Endocrinol Metab; 2007 Mar; 92(3):1058-65. PubMed ID: 17179194
    [Abstract] [Full Text] [Related]

  • 10. Disseminated thyroid autonomy or Graves' disease: reevaluation by a second generation TSH receptor antibody assay.
    Meller J, Jauho A, Hüfner M, Gratz S, Becker W.
    Thyroid; 2000 Dec; 10(12):1073-9. PubMed ID: 11201852
    [Abstract] [Full Text] [Related]

  • 11. TSH-receptor antibody measurement for differentiation of hyperthyroidism into Graves' disease and multinodular toxic goitre: a comparison of two competitive binding assays.
    Pedersen IB, Knudsen N, Perrild H, Ovesen L, Laurberg P.
    Clin Endocrinol (Oxf); 2001 Sep; 55(3):381-90. PubMed ID: 11589682
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles.
    Sato K, Yamazaki K, Yamada E, Kanaji Y, Miura M, Obara T.
    Thyroid; 1999 Oct; 9(10):979-88. PubMed ID: 10560951
    [Abstract] [Full Text] [Related]

  • 14. Diagnostic sensitivity of two radio receptor assays (TRAK Assay and TRAK Dyno Human) for detection of TSH receptor antibodies.
    Paunkovic N, Paunkovic J.
    Nucl Med Rev Cent East Eur; 2003 Oct; 6(2):119-22. PubMed ID: 14737725
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Antibodies to TSH-receptor in thyroid autoimmune disease interact with monoclonal antibodies whose epitopes are broadly distributed on the receptor.
    Minich WB, Lenzner C, Morgenthaler NG.
    Clin Exp Immunol; 2004 Apr; 136(1):129-36. PubMed ID: 15030524
    [Abstract] [Full Text] [Related]

  • 17. Similar clinical performance of a novel chimeric thyroid-stimulating hormone receptor bioassay and an automated thyroid-stimulating hormone receptor binding assay in Graves' disease.
    Kamijo K, Murayama H, Uzu T, Togashi K, Olivo PD, Kahaly GJ.
    Thyroid; 2011 Dec; 21(12):1295-9. PubMed ID: 22066477
    [Abstract] [Full Text] [Related]

  • 18. [The relationship between serum thyroid autoantibodies, iodine intake, development and prognosis of Graves' disease].
    Chen W, Man N, Li YS, Shan ZY, Teng WP.
    Zhonghua Nei Ke Za Zhi; 2006 Feb; 45(2):95-9. PubMed ID: 16624113
    [Abstract] [Full Text] [Related]

  • 19. Thyroid-stimulating antibody and TSH-binding inhibitor immunoglobulin in 277 Graves' patients and in 686 normal subjects.
    Takasu N, Oshiro C, Akamine H, Komiya I, Nagata A, Sato Y, Yoshimura H, Ito K.
    J Endocrinol Invest; 1997 Sep; 20(8):452-61. PubMed ID: 9364248
    [Abstract] [Full Text] [Related]

  • 20. Induction of TSH-receptor antibodies in patients with toxic multinodular goitre by radioiodine treatment.
    Wallaschofski H, Müller D, Georgi P, Paschke R.
    Horm Metab Res; 2002 Jan; 34(1):36-9. PubMed ID: 11833000
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.